Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Cell Analysis Global Market estimated to be worth $39.3 billion by 2025Live-cell imaging, single-cell analysis, and high content screening (HCS) are few technologies where individual cells are analyzed for in their natural states are gaining prominence in the cell analysis market.
According to IQ4I analysis, the cell analysis global market is estimated to grow at high single digit CAGR to reach $39.3 billion by 2025. Some of the factors driving the market are raising incidence of life-threatening infectious diseases, increasing funding and investments in cell-based research from government and corporate, high demand for cell analysis products by end-users, emerging Asia-Pacific market, emerging cell analysis service providers and introduction of automation technologies in cancer research. However, stringent government regulations, lack of skilled personnel to use advanced cell analysis Instruments, and the high cost of some of the instruments are expected to hamper the market growth. The report covers information such as, analysis of segments by techniques, products, applications end-users and geography, market share analysis by major players and single-cell analysis, and cost of major devices. Also includes, Profiles of major players and analysis of their revenue, business strategies, SWOTs and market share. Major players in cell analysis market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Merck KGaA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) For more details please visit our website or contact: Mr. Satish Birudukota, Website: https://www.iq4i.com Report link: https://www.iq4i.com/ Email: bd@iq4i.com, Phone: 8147030229, End
Account Phone Number Disclaimer Report Abuse
|
|